アース製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2013/12/16 | 3,800 | 3,815 | 3,760 | 3,760 | -55 | -1.4% | 111,800 |
2013/12/13 | 3,815 | 3,830 | 3,805 | 3,815 | +15 | +0.4% | 161,400 |
2013/12/12 | 3,800 | 3,815 | 3,800 | 3,800 | +15 | +0.4% | 87,600 |
2013/12/11 | 3,770 | 3,800 | 3,770 | 3,785 | +10 | +0.3% | 88,200 |
2013/12/10 | 3,750 | 3,785 | 3,750 | 3,775 | +25 | +0.7% | 84,200 |
2013/12/09 | 3,750 | 3,780 | 3,740 | 3,750 | +10 | +0.3% | 112,500 |
2013/12/06 | 3,700 | 3,750 | 3,700 | 3,740 | +30 | +0.8% | 104,400 |
2013/12/05 | 3,700 | 3,750 | 3,695 | 3,710 | +30 | +0.8% | 260,100 |
2013/12/04 | 3,690 | 3,700 | 3,680 | 3,680 | -15 | -0.4% | 63,400 |
2013/12/03 | 3,695 | 3,700 | 3,690 | 3,695 | +5 | +0.1% | 71,400 |
2013/12/02 | 3,680 | 3,700 | 3,680 | 3,690 | +20 | +0.5% | 64,100 |
2013/11/29 | 3,650 | 3,675 | 3,645 | 3,670 | +30 | +0.8% | 69,900 |
2013/11/28 | 3,645 | 3,650 | 3,635 | 3,640 | ±0 | ±0% | 37,600 |
2013/11/27 | 3,640 | 3,655 | 3,630 | 3,640 | ±0 | ±0% | 73,900 |
2013/11/26 | 3,650 | 3,650 | 3,640 | 3,640 | -10 | -0.3% | 44,900 |
2013/11/25 | 3,645 | 3,650 | 3,635 | 3,650 | +5 | +0.1% | 50,300 |
2013/11/22 | 3,640 | 3,650 | 3,635 | 3,645 | +5 | +0.1% | 53,400 |
2013/11/21 | 3,630 | 3,640 | 3,625 | 3,640 | ±0 | ±0% | 67,900 |
2013/11/20 | 3,640 | 3,640 | 3,625 | 3,640 | +10 | +0.3% | 14,000 |
2013/11/19 | 3,645 | 3,650 | 3,620 | 3,630 | -10 | -0.3% | 52,900 |
2013/11/18 | 3,650 | 3,650 | 3,635 | 3,640 | ±0 | ±0% | 23,000 |
2013/11/15 | 3,630 | 3,645 | 3,615 | 3,640 | +15 | +0.4% | 42,100 |
2013/11/14 | 3,620 | 3,625 | 3,610 | 3,625 | ±0 | ±0% | 43,400 |
2013/11/13 | 3,610 | 3,635 | 3,610 | 3,625 | ±0 | ±0% | 23,400 |
2013/11/12 | 3,625 | 3,630 | 3,610 | 3,625 | ±0 | ±0% | 35,600 |
2013/11/11 | 3,620 | 3,630 | 3,610 | 3,625 | +15 | +0.4% | 11,400 |
2013/11/08 | 3,610 | 3,640 | 3,605 | 3,610 | -10 | -0.3% | 18,800 |
2013/11/07 | 3,640 | 3,645 | 3,610 | 3,620 | -20 | -0.5% | 21,400 |
2013/11/06 | 3,650 | 3,650 | 3,620 | 3,640 | -10 | -0.3% | 31,200 |
2013/11/05 | 3,640 | 3,650 | 3,625 | 3,650 | +30 | +0.8% | 33,400 |
2013/11/01 | 3,650 | 3,660 | 3,620 | 3,620 | -30 | -0.8% | 24,500 |
2013/10/31 | 3,670 | 3,675 | 3,640 | 3,650 | -5 | -0.1% | 21,300 |
2013/10/30 | 3,620 | 3,660 | 3,620 | 3,655 | +35 | +1% | 22,800 |
2013/10/29 | 3,620 | 3,645 | 3,620 | 3,620 | -10 | -0.3% | 22,700 |
2013/10/28 | 3,605 | 3,645 | 3,605 | 3,630 | +5 | +0.1% | 18,100 |
2013/10/25 | 3,685 | 3,685 | 3,625 | 3,625 | -30 | -0.8% | 20,400 |
2013/10/24 | 3,605 | 3,660 | 3,605 | 3,655 | +45 | +1.2% | 18,600 |
2013/10/23 | 3,650 | 3,670 | 3,610 | 3,610 | -50 | -1.4% | 26,000 |
2013/10/22 | 3,690 | 3,690 | 3,645 | 3,660 | -30 | -0.8% | 20,500 |
2013/10/21 | 3,675 | 3,695 | 3,670 | 3,690 | +15 | +0.4% | 8,900 |
2013/10/18 | 3,675 | 3,690 | 3,670 | 3,675 | +10 | +0.3% | 16,600 |
2013/10/17 | 3,610 | 3,670 | 3,610 | 3,665 | +55 | +1.5% | 25,900 |
2013/10/16 | 3,625 | 3,645 | 3,600 | 3,610 | -10 | -0.3% | 18,300 |
2013/10/15 | 3,650 | 3,650 | 3,610 | 3,620 | -25 | -0.7% | 13,100 |
2013/10/11 | 3,620 | 3,650 | 3,615 | 3,645 | +40 | +1.1% | 33,200 |
2013/10/10 | 3,575 | 3,610 | 3,575 | 3,605 | +55 | +1.5% | 16,600 |
2013/10/09 | 3,500 | 3,550 | 3,490 | 3,550 | +25 | +0.7% | 17,600 |
2013/10/08 | 3,540 | 3,545 | 3,500 | 3,525 | -50 | -1.4% | 47,200 |
2013/10/07 | 3,600 | 3,610 | 3,540 | 3,575 | -35 | -1% | 36,000 |
2013/10/04 | 3,610 | 3,620 | 3,600 | 3,610 | -10 | -0.3% | 18,400 |
2801~
2850
件表示中 / 4777件
類似銘柄と比較する
現在ご覧いただいている「アース製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アース製薬 | 492,000円 | +3.4% | -3.6% | 2.44% | 25.00倍 | 1.56倍 |
|
殺虫剤(虫ケア用品)首位、口腔衛生用品他日用品も。大塚製薬グループ。傘下にバスクリン、白元 |
中国塗 | 227,200円 | +1.4% | +0.1% | 4.27% | 10.24倍 | 1.35倍 |
|
塗料3位。船舶用は国内シェア6割、世界2位。世界20カ国、約60拠点で展開。修繕船向けが成長 |
クミアイ化 | 83,900円 | -1.1% | -20.8% | 4.05% | 9.27倍 | 0.69倍 |
|
全農系農薬専業首位、環境負荷低減の新製品開発を推進。化成品強化課題。配当性向3割超目標 |
サカタインクス | 196,000円 | +9.1% | +24.1% | 4.59% | 8.99倍 | 0.86倍 |
|
印刷インキ3位。北米、アジアなど海外先行。DICと国内効率化で提携。非インキ事業を育成中 |
タカラバイオ | 78,700円 | +16.6% | -3.5% | 2.16% | 72.87倍 | 0.82倍 |
|
研究用試薬・機器が主力。再生医療等製品や遺伝子解析・検査など受託のCDMO事業に展開 |
市場注目の銘柄
チャート関連のコラム